ibandronate (boniva)

The Ibandronate (Boniva) Drug
Name
Institution
Date
Abstract
The Ibandronate is an intravenous and an orally taken drug which is meant for treatment of osteoporosis. Upon the classification of drugs, it belongs to bisphosphonate class which is composed of tiludronate (Skelid), etidronate (Didronel), risedronate (Actonel) as well as pamidronate (Aredia). The Ibandronate belongs to a Bisphosphonates class; it helps in strengthening of bones by restraining bone discharge by the osteoclasts. After the menopause, high chances bone losses increases are resulting in osteoporosis. Upon the application precautions, the Ibandronate drug needs to be administered for at least one hour before taking in of any other oral medication more specifically those that aluminium, calcium, iron or magnesium as they decrease the consumption of ibandronate. The ibandronate is not healthy for the pregnant women. The Ibandronate should be used during pregnancy only if the doctor feels that its potential benefit warrants the potential danger to the fetus. Therefore, it cannot be healthy for pregnant women.
Introduction
The Ibandronate is an intravenous and an orally taken drug which is meant for treatment of osteoporosis. Upon the classification of drugs, it belongs to bisphosphonate class which is composed of tiludronate (Skelid), etidronate (Didronel), risedronate (Actonel) as well as pamidronate (Aredia).
How the Ibandronate works
Bone is always in a continuous state of regeneration. The osteoblasts process enhances the process laying down the new bones whereas osteoclasts are the process through which cells remove the old bones from the body (Reginster et al.

, 2006). Since Ibandronate belongs to a Bisphosphonates class, it helps in strengthening of bones by restraining bone discharge by the osteoclasts. After the menopause, high chances bone losses increases are resulting in osteoporosis. Therefore, Ibandronate very useful in increasing the density as well as decreasing the fracturing more so after one reaches menopause.
Precaution upon taking the Ibandronate drug.
The Ibandronate drug needs to be applied for at least one hour before taking in of any other oral medication more specifically those that comprises aluminium, calcium, iron or magnesium as they decrease the consumption of ibandronate (Reginster et al., 2006). Secondly, after taking in ibandronate drug one should wait for at least one-hour before taking any medication. In case one takes in drugs such as aspirin as well as nonsteroidal anti-inflammatory drugs (NSAIDs) he or she experiences irritation in the intestine and the stomach. Finally, the ibandronate is not healthy for the pregnant women. The Ibandronate should be used during pregnancy only if the doctor feels that its potential benefit warrants the potential danger to the fetus.
In a nutshell, the Ibandronate drug is significant when it comes to curing of osteoporosis.it is highly recommended when ones get reaches the menopause stage when his or her bones are at a high chance of fracturing easily. Therefore, al the old people should regularly use the Ibandronate.
Reference
Reginster, J. Y., Adami, S., Lakatos, P., Greenwald, M., Stepan, J. J., Silverman, S. L., & Drezner, M. K. (2006). Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Annals of the rheumatic diseases, 65(5), 654-661.